Latest Posts

30

May 24

Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development

Frankfurt, Germany, 3rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled...
Read More

22

Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More
Try Ontosight® For Free

Gaining Momentum: Ex – President, Merck KGaA (Latin America), Lawrence Ganti joins Innoplexus as CEO, Americas

Innoplexus AG, a leading AI based analytics as a service provider in life sciences and financial services domain, announced today appointment of Lawrence Ganti as Chief Executive Officer of Innoplexus, Americas, further strengthening its leadership team.

Lawrence is widely respected as exceptional team builder and accomplished leader in Pharma Industry. His addition to leadership team will play crucial role in our company’s transformational journey”, said Dr. Gunjan Bhardwaj, Global CEO, Innoplexus.

Lawrence brings over 20 years of experience in healthcare, technology, and consumer goods where he has worked across general management, commercial development, strategy formulation, and marketing. Amongst his many achievements, Lawrence led the post merger integration of Merck and Serono’s international business; implemented a turnaround of Merck’s business in India; spearheaded a transformation of the Latin America operations; and launched an award winning marketing campaign in Japan.

Prior to joining Innoplexus, he built an impressive career over 14 years with Merck KGaA, where he held various leadership positions across Europe, Asia, and Latin America. Most recently Lawrence held the position of President – Latin America at Merck. He started his career with PepsiCo, Marriott, and Johnson & Johnson, then moved to McKinsey & Company before taking on business development roles for various technology startups. Lawrence holds an MBA from IMD In Switzerland and BS in Entrepreneurship from Babson College, USA. He will be based out of New Jersey, USA.

Featured News

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce…